$1.74 Billion in Sales Expected for Clorox Co (NYSE:CLX) This Quarter

Share on StockTwits

Equities analysts expect that Clorox Co (NYSE:CLX) will report $1.74 billion in sales for the current fiscal quarter, Zacks reports. Three analysts have provided estimates for Clorox’s earnings. The highest sales estimate is $1.76 billion and the lowest is $1.73 billion. Clorox reported sales of $1.51 billion during the same quarter last year, which would suggest a positive year-over-year growth rate of 15.2%. The company is scheduled to announce its next earnings report before the market opens on Monday, November 2nd.

On average, analysts expect that Clorox will report full-year sales of $6.94 billion for the current financial year, with estimates ranging from $6.86 billion to $7.04 billion. For the next fiscal year, analysts expect that the firm will post sales of $7.19 billion, with estimates ranging from $7.12 billion to $7.24 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of sell-side research analysts that that provide coverage for Clorox.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Monday, August 3rd. The company reported $2.41 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.00 by $0.41. The company had revenue of $1.98 billion during the quarter, compared to analyst estimates of $1.86 billion. Clorox had a net margin of 13.97% and a return on equity of 138.70%. Clorox’s quarterly revenue was up 21.9% compared to the same quarter last year. During the same period last year, the business earned $1.88 EPS.

Several research analysts recently issued reports on CLX shares. JPMorgan Chase & Co. increased their price target on shares of Clorox from $203.00 to $235.00 and gave the stock an “overweight” rating in a research note on Thursday, July 16th. DA Davidson decreased their price target on shares of Clorox from $269.00 to $263.00 and set a “buy” rating for the company in a research note on Wednesday. Morgan Stanley increased their price target on shares of Clorox from $193.00 to $197.00 and gave the stock an “underweight” rating in a research note on Tuesday, August 4th. Deutsche Bank raised their price objective on shares of Clorox from $174.00 to $223.00 and gave the company a “hold” rating in a research note on Monday, July 27th. Finally, Zacks Investment Research lowered shares of Clorox from a “buy” rating to a “hold” rating and set a $249.00 price objective for the company. in a research note on Thursday, August 6th. Three equities research analysts have rated the stock with a sell rating, seven have given a hold rating and three have issued a buy rating to the company’s stock. Clorox has an average rating of “Hold” and a consensus target price of $206.54.

Shares of Clorox stock traded down $2.43 during trading on Wednesday, hitting $209.22. The company’s stock had a trading volume of 1,311,353 shares, compared to its average volume of 1,379,446. The company has a debt-to-equity ratio of 3.06, a quick ratio of 1.10 and a current ratio of 1.42. The company has a fifty day simple moving average of $216.80 and a two-hundred day simple moving average of $208.16. The company has a market capitalization of $26.36 billion, a PE ratio of 28.47, a P/E/G ratio of 3.85 and a beta of 0.27. Clorox has a 52 week low of $144.31 and a 52 week high of $239.87.

The business also recently declared a quarterly dividend, which will be paid on Friday, November 20th. Stockholders of record on Wednesday, November 4th will be issued a dividend of $1.11 per share. This represents a $4.44 dividend on an annualized basis and a dividend yield of 2.12%. The ex-dividend date is Tuesday, November 3rd. Clorox’s payout ratio is presently 60.33%.

In other news, SVP Andrew J. Mowery sold 12,932 shares of the firm’s stock in a transaction dated Thursday, August 6th. The shares were sold at an average price of $235.97, for a total transaction of $3,051,564.04. Following the sale, the senior vice president now owns 18,456 shares of the company’s stock, valued at approximately $4,355,062.32. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, SVP Diego J. Barral sold 10,041 shares of the firm’s stock in a transaction dated Tuesday, August 4th. The shares were sold at an average price of $235.59, for a total transaction of $2,365,559.19. Following the sale, the senior vice president now directly owns 13,931 shares in the company, valued at approximately $3,282,004.29. The disclosure for this sale can be found here. Company insiders own 1.14% of the company’s stock.

Several hedge funds and other institutional investors have recently made changes to their positions in CLX. Costello Asset Management INC purchased a new position in shares of Clorox in the second quarter worth approximately $27,000. RPG Investment Advisory LLC boosted its holdings in shares of Clorox by 98.5% in the second quarter. RPG Investment Advisory LLC now owns 129 shares of the company’s stock worth $28,000 after buying an additional 64 shares during the last quarter. Rosenberg Matthew Hamilton purchased a new position in shares of Clorox in the second quarter worth approximately $29,000. Healthcare of Ontario Pension Plan Trust Fund purchased a new position in shares of Clorox in the second quarter worth approximately $30,000. Finally, Knuff & Co LLC boosted its holdings in shares of Clorox by 174.0% in the second quarter. Knuff & Co LLC now owns 137 shares of the company’s stock worth $30,000 after buying an additional 87 shares during the last quarter. 79.18% of the stock is currently owned by hedge funds and other institutional investors.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

Further Reading: What are popular green investing opportunities?

Get a free copy of the Zacks research report on Clorox (CLX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply